The underlying cause for enzymatic catalysis is stabilization of the transition state by interactions with the protein catalyst.^[@ref1]^ Orotidine 5′-monophosphate decarboxylase (OMPDC) affects a 31 kcal/mol stabilization of the transition state for decarboxylation of orotidine 5′-monophosphate (OMP) to give uridine 5′-monophosphate (UMP),^[@ref2]^ by a stepwise mechanism through a UMP carbanion intermediate ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref3]^ This transition state stabilization has been modeled in computational studies.^[@ref4]^ What has not been fully modeled is the extraordinary specificity of OMPDC in binding the decarboxylation transition state with a higher affinity (31 kcal/mol) compared with the substrate OMP (8 kcal/mol).^[@ref2],[@ref5]^

![Substrate Fragments of OMP that Provide the Binding Energy Utilized in the Stabilization of the UMP Carbanion Intermediate of OMPDC-Catalyzed Decarboxylation.](ja-2017-08897h_0004){#sch1}

Binding interactions between OMPDC and the phosphodianion of OMP provide 12 of the 31 kcal/mol transition state stabilization.^[@ref6]^ These interactions do not only anchor OMP to the protein, because eliminating the anchoring connection results in only a 4 kcal/mol decrease, to 8 kcal/mol, in the stabilization of the transition state for decarboxylation of the truncated substrate piece 1-(β-[d]{.smallcaps}-erythrofuranosyl)orotate (**EO**) from interactions with 1.0 M phosphite dianion ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A).^[@ref6],[@ref7]^ This activation is due to the utilization of binding energy from interactions between OMPDC and activator (Act, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) to drive a complex conformational change from inactive open OMPDC (**E**~**O**~) to the active closed caged complex (**E**~**C**~),^[@ref8]^ where **E**~**C**~ is stabilized relative to **E**~**O**~ by interactions between dianions and the side chains of Q215, Y217, and R235.^[@ref9]^

![Activation of OMPDC-catalyzed decarboxylation reactions. (A) Activation of decarboxylation of **EO** and **FEO** by HPO~3~^2--^.^[@ref6],[@ref10]^ (B) Activation of decarboxylation of **FO** by HPO~3~^2--^. (C, D) Activation of decarboxylation of **FO** by [d]{.smallcaps}-glycerol 3-phosphate (DG3P) and [d]{.smallcaps}-erythritol 4-phosphate (DE4P), respectively.](ja-2017-08897h_0001){#fig1}

[Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A shows a representation of the open form of OMPDC determined for unliganded OMPDC from yeast (**E**~**O**~, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), with a hypothetical 6-aza uridine 5′-monophosphate (**azaUMP**) ligand inserted at the position determined for the OMPDC·**azaUMP** complex ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B).^[@ref11]^ Many ligands induce a large conformational change in OMPDC that is driven by the development of strong protein--ligand interactions.^[@ref12]^ The interactions between the protein and the phosphodianion, or the ribosyl hydroxyls, which develop at the complex to the tight-binding inhibitor **azaUMP** \[or to substrate analogs\],^[@ref12]^ are illustrated in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B for the closed form of OMPDC (**E**~**C**~).^[@ref11]^ Our model ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) requires that the binding energy from all interactions that drive the conformational change from **E**~**O**~ to **E**~**C**~ activate OMPDC for catalysis, as has been demonstrated for protein--dianion interactions,^[@ref6],[@ref10],[@ref13]^ because these interactions are only fully expressed at the decarboxylation transition state. This prediction is confirmed here by the observation that binding interactions between OMPDC and either phosphite dianion ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B) or sugar hydroxyls ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C and [1](#fig1){ref-type="fig"}D) activate OMPDC for catalysis of decarboxylation of the definitive truncated substrate, 5-fluoroorotate (**FO)**.

![The Role of an Activator-Driven Conformational Change in Catalysis by OMPDC.](ja-2017-08897h_0005){#sch2}

![Representations of the open **E**~**O**~ (PDB entry 3GDK) and the closed, liganded, (B, 3GDL) forms of yeast OMPDC.^[@ref11]^ The **azaUMP** ligand is placed at structure A at the position determined for structure B. The ligand is stabilized by interactions from the side chains of R235 and Q215 with the phosphodianion, and of the D96, H61, D37 and K59 with the ribosyl hydroxyls.](ja-2017-08897h_0002){#fig2}

The slow decarboxylation of **FO** to form 5-fluorouracil (**FU**) catalyzed by yeast OMPDC was monitored by HPLC analyses, as described in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf) (SI). Observed first-order rate constants *k*~obs~ = *v*/\[E\] for the decarboxylation of **FO** (5 or 10 mM) catalyzed by 0.7 mM OMPDC at 25 °C were determined from the initial reaction velocity *v* during the first 0.01% reaction, over a two-week reaction time, during which OMPDC maintained full activity. The second-order rate constant (*k*~cat~/*K*~m~)~o~ = (1.4 ± 0.1) × 10^--7^ M^--1^ s^--1^ for OMPDC-catalyzed decarboxylation of **FO** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) was determined as the slope of the linear plot of *k*~obs~ = *v*\[E\] against \[**FO**\] ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). These apparent first-order rate constants from HPLC analyses are reproducible to better than ±10%. The 5-F substituent provides strong stabilization of the UMP carbanion intermediate of OMPDC-catalyzed reactions.^[@cit3a],[@ref10],[@cit13b],[@ref14]^ The value of (*k*~cat~/*K*~m~)~o~ = 3 × 10^--10^ M^--1^ s^--1^ for OMPDC-catalyzed decarboxylation of orotate ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) was determined from (*k*~cat~/*K*~m~)~o~ = 1.4 × 10^--7^ M^--1^ s^--1^ for decarboxylation of **FO** and a 500-fold effect of the 5-F substituent. This is a rough average of the 5-F effect on mutant OMPDC-catalyzed decarboxylation of **OMP**, when chemistry is strongly rate determining for both OMPDC-catalyzed reactions.^[@ref14]^

![Plots of kinetic data for OMPDC-catalyzed decarboxylation of **FO**. (A) The dependence of *k*~obs~ = *v*\[E\] on \[**FO**\]. (B) The dependence of (*k*~cat~/*K*~m~)~obs~ for OMPDC-catalyzed decarboxylation of **FO** on \[HPO~3~^2--^\]. (C) The dependence of (*k*~cat~/*K*~m~)~obs~ for OMPDC-catalyzed decarboxylation of **FO** on the concentration of DE4P.](ja-2017-08897h_0003){#fig3}

###### Contribution of the IBE from Substrate Fragments to the 31 kcal/mol IBE of OMP^[@ref2]^ for OMPDC[a](#t1fn1){ref-type="table-fn"}

  Substrate   *k*~cat~/*K*~m~ (M^--1^ s^--1^)[b](#t1fn2){ref-type="table-fn"}   Fragment[c](#t1fn3){ref-type="table-fn"}   Fragment IBE (kcal/mol)[d](#t1fn4){ref-type="table-fn"}
  ----------- ----------------------------------------------------------------- ------------------------------------------ ---------------------------------------------------------
  **FO**      (1.4 ± 0.1) × 10^--7^[e](#t1fn5){ref-type="table-fn"}                                                         
  Orotate     3 × 10^--10^[f](#t1fn6){ref-type="table-fn"}                      H                                          0
  **EO**      0.02                                                              [d]{.smallcaps}-Erythrose                  10.6
  **OMP**     1 × 10^7^                                                         Ribose 5′-Phosphate                        10.6 + 11.8

At 25 °C, pH 7.0 and *I* = 0.14--0.15 (NaCl).

Second-order rate constant for decarboxylation catalyzed by OMPDC.

Fragment attached to orotate.

Contribution of fragment to the stabilization of the transition state for OMPDC catalyzed decarboxylation of **OMP**.

[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A.

See text.

A comparison of the second-order rate constants *k*~cat~/*K*~m~ for OMPDC-catalyzed decarboxylation of orotate, **EO**, and **OMP** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) shows that the ribosyl and phosphodianion fragments contribute 10.6 and 11.8 kcal/mol intrinsic binding energies, respectively, to stabilization of the transition state for OMPDC-catalyzed decarboxylation of OMP: the sum is 22.4 kcal/mol of the total 31 kcal/mol total intrinsic binding energy of OMP, leaving 8.6 kcal/mol for stabilization of the transition state by interactions with orotate.^[@ref2]^ This provides a graphic and readily generalizable illustration of how enormous enzymatic rate accelerations may be obtained through recruitment of several modest, additive, binding energies of substrate fragments.

[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B,C shows the effect of increasing \[HPO~3~^2--^\] and \[DE4P\], respectively, on (*k*~cat~/*K*~m~)~obs~ for OMPDC-catalyzed decarboxylation of **FO** (5 mM). These data were fit to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}A) to give the values for (*k*~cat~/*K*~m~)~Act~ and *K*~d~ reported in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} reports values for (*k*~cat~/*K*~m~)~Act~/*K*~d~ obtained as the slope of the linear correlations shown as dashed lines in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B,C. Data for the effect of increasing \[D,LG3P\] ([Figure S1A](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf)) and \[LG3P\] ([Figure S1B](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf)) on (*k*~cat~/*K*~m~)~obs~ for OMPDC-catalyzed decarboxylation of **FO** were evaluated to give the kinetic parameters in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The value of (*k*~cat~/*K*~m~)~Act~/*K*~d~ for OMPDC-catalyzed decarboxylation of DG3P was calculated from these kinetic parameters using [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, where (*k*~Act~)~XG3P~ = \[(*k*~cat~/*K*~m~)~Act~/*K*~d~)\]~XG3P~ (X = D, L, or D, L). The intrinsic fragment binding energies (IBEs), determined using [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"} ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}B), are reported in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.

![(a) Kinetic Scheme Used for the Derivation of [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}. (b) Kinetic Scheme Used for the Derivation of [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"}.](ja-2017-08897h_0006){#sch3}

###### Kinetic Parameters for Unactivated and Activated OMPDC-Catalyzed Decarboxylation of FO[a](#t2fn1){ref-type="table-fn"}

  Activator                                                                 (*k*~cat~/*K*~m~)~Act~ M^--1^ s^--1^[b](#t2fn2){ref-type="table-fn"}   *K*~d~ (M)[c](#t2fn3){ref-type="table-fn"}   \[(*k*~cat~/*K*~m~)~Act~\]/*K*~d~ M^--2^ s^--1^[d](#t2fn4){ref-type="table-fn"}   IBE (kcal/mol)[e](#t2fn5){ref-type="table-fn"}
  ------------------------------------------------------------------------- ---------------------------------------------------------------------- -------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------
  HP~i~[f](#t2fn6){ref-type="table-fn"}                                     (1.6 ± 0.4) × 10^--4^                                                  0.18 ± 0.05                                  (8.4 ± 0.4) × 10^--4^                                                             5.2
  D,LG3P[g](#t2fn7){ref-type="table-fn"}                                    (7.0 ± 0.7) × 10^--4^                                                  0.05 ± 0.01                                  (1.3 ± 0.1) × 10^--2^                                                             6.8
  LG3P[g](#t2fn7){ref-type="table-fn"}^,^[h](#t2fn8){ref-type="table-fn"}                                                                                                                       (9.9 ± 0.2) × 10^--4^                                                             5.2
  DG3P[i](#t2fn9){ref-type="table-fn"}                                                                                                                                                          (2.5 ± 0.01) × 10^--2^                                                            7.2
  DE4P[j](#t2fn10){ref-type="table-fn"}                                     (1.9 ± 0.2) × 10^--2^                                                  0.030 ± 0.003                                (6.0 ± 0.2) × 10^--1^                                                             9.0
  DR5P[g](#t2fn7){ref-type="table-fn"}                                                                                                                                                          ≈3 × 10^--5^                                                                      3.1

At 25 °C, pH 7.0 and *I* = 0.15 (NaCl). The quoted errors are the standard deviations from the least-squares fits of the data.

Second-order rate constant for breakdown of E·Act·**FO** to form **FU**.

Dissociation constant for the activator.

Determined as described in the text.

Fragment intrinsic binding energy, calculated as −*RT*ln*K*^‡^ ([eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"}).

[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B.

See [SI](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf).

No detectable saturation of OMPDC.

Calculated from [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, where (*k*~Act~) = \[(*k*~cat~/*K*~m~)~Act~\]/*K*~d~ from [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}A.

[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C.

Phosphite dianion (1.0 M) provides similar 5.0^[@ref10]^ and 5.2 ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) kcal/mol stabilization, respectively, of the transition states for OMPDC-catalyzed decarboxylation of truncated substrates 1-(β-[d]{.smallcaps}-erythrofuranosyl)-5-fluoroorotate (**FEO**) and **FO**. The small apparent effect of the ribosyl group of **FEO** on activation for decarboxylation shows that the effect of the dianion driven protein conformational change on the reactivity of the fluoroorotate ring is transmitted across both the ribosyl group and the vacant protein core. DG3P and DE4P provide 7.2 and 9.0 kcal/mol transition state stabilization, respectively, which corresponds to *ca*. 2 kcal/mol transition state stabilization/sugar hydroxyl. OMPDC shows specificity for activation by DG3P, because the IBE determined for LG3P is similar to that for HPO~3~^2--^ alone. The small activation of OMPDC-catalyzed decarboxylation of **FO** for a reaction in the presence of 40 mM [d]{.smallcaps}-ribose 5′-phosphate (DR5P, [SI](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf)) is consistent with a ligand IBE of only 3.1 kcal/mol ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). This shows that a tight and precise fit of the ligand is required for strong transition state binding.^[@ref10]^

These results provide strong support for the conclusion that each of the many OMPDC--substrate interactions, which stabilize the closed enzyme **E**~**C**~ relative to the open enzyme **E**~**O**~, contribute to activation of OMPDC for catalysis of decarboxylation of orotate and fluoroorotate rings. We conclude that these protein--ligand interactions act in concert to construct a tight, catalytically active form of OMPDC from the floppy open enzyme. These results provide a dramatic example of the effect of such preorganization of protein structure on enzyme activity.^[@ref15]^

X-ray crystallographic analyses and other protocols for the evaluation of the role of conformational changes in enzyme catalysis, failed to suggest the activating nature of phosphodianion driven conformational changes in catalysis by triosephosphate isomerase, and other enzymes.^[@cit7b],[@ref16]^ Our report of the, likewise, unrecognized activating role of protein sugar--hydroxyl interactions in catalysis by OMPDC provides compelling motivation for a re-evaluation of the role of substrate-driven conformational changes in enzyme catalysis;^[@cit1b],[@cit8a],[@cit8b],[@ref17]^ and, for experiments to test the hypothesis that many, or most, such protein conformational changes activate enzymes for catalysis of the reaction of their bound substrates.

Experiments to probe the activation of OMPDC by substrate induced conformational changes have outpaced other mechanistic studies on this enzyme. Consequently, there is now strong evidence that the binding interactions of the nonreacting substrate parts are used to construct a protein cage that shows a high reactivity toward substrate decarboxylation. The results of our earlier work have emphasized the role the protein plays in strongly stabilizing the UMP carbanion intermediate relative to the carbon acid substrate.^[@ref3]^ This suggests that an unusually strong stabilization of this carbanion by interaction with the cationic side chain of K93.^[@cit4c],[@cit16a]^ This single interaction seems unlikely to enable the entire rate acceleration, so that there remains much to be learned about the origin of the high-reactivity of the caged OMPDC--substrate complex

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/jacs.7b08897](http://pubs.acs.org/doi/abs/10.1021/jacs.7b08897).References for experimental procedures used to purify yeast OMPDC, and a description of the procedures for the assay of OMPDC-catalyzed decarboxylation of **FO**; kinetic data for the activation of OMPDC by [d]{.smallcaps}-ribose 5′-phosphate; effect on increasing \[LG3P\] and \[D,LG3P\], respectively on (*k*~cat~/*K*~m~)~obs~ for OMPDC-catalyzed decarboxylation of **FO** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/jacs.7b08897/suppl_file/ja7b08897_si_001.pdf))
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